Management of Hyperhidrosis

Overview

Journal Clin Cosmet Investig Dermatol

Publisher Dove Medical Press

Specialty Dermatology

Date 2014 Nov 8

PMID 25378942

Citations 16

Authors

Anna-Bianca Stashak

Jerry D Brewer

Affiliations

Soon will be listed here.

Abstract

Primary hyperhidrosis (HH), a condition of sweating in excess of thermoregulatory requirements, affects nearly 3% of the US population and carries significant emotional and psychosocial implications. Unlike secondary HH, primary HH is not associated with an identifiable underlying pathology. Our limited understanding of the precise pathophysiologic mechanism for HH makes its treatment particularly frustrating. However, a wide array of interventions for the treatment of HH have been implemented throughout the world. Herein, we discuss the most extensively studied therapeutic options for primary HH, including systemic oxybutynin, botulinum toxin injections, skin excision, liposuction-curettage, and sympathotomy/sympathectomy. We conclude with a discussion of possible future therapies for HH, including the applications of laser, microwave, and ultrasound technologies.

Citing Articles

Longitudinal Assessment of Facial Hyperhidrosis Management: Evaluating the Utility and Quality of Life Improvements following Botulinum Toxin Injection.

Prodan-Barbulescu C, Castiglione L, Burtic S, Murariu M, Reddy S, Rosca O Toxins (Basel). 2024; 16(1).

PMID: 38276535 PMC: 10820190. DOI: 10.3390/toxins16010059.

Enhancing Quality of Life: Pre- and Postoperative Assessment in Idiopathic Hyperhidrosis Patients.

Estrella-Gaibor C, Rivero Y, Jaramillo-Montano F, Veitia L, Cordova Guilarte J, Garcia A Cureus. 2023; 15(11):e49588.

PMID: 38156137 PMC: 10754539. DOI: 10.7759/cureus.49588.

Relationship Between the Type of Allergen and Night Sweat in Allergic Children.

Aydogdu A, Ozdemir A Cureus. 2023; 15(11):e48174.

PMID: 38046775 PMC: 10693384. DOI: 10.7759/cureus.48174.

Low-Dose OnabotulinumtoxinA using Seven-Point Pattern Intradermal Injections in Patients with Moderate-to-intolerable Primary Axillary Hyperhidrosis: A Single-Blinded, Side-by-Side Randomized Trial.

Siri-Archawawat D, Tawanwongsri W J Clin Aesthet Dermatol. 2023; 16(6):37-43.

PMID: 37361360 PMC: 10286880.

Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics.

Wong N, Adlam T, Potts G, Farshchian M Dermatol Ther (Heidelb). 2022; 12(12):2705-2714.

PMID: 36329359 PMC: 9674821. DOI: 10.1007/s13555-022-00838-3.

References

Leseche G, Castier Y, Thabut G, Petit M, Combes M, Cerceau O . Endoscopic transthoracic sympathectomy for upper limb hyperhidrosis: limited sympathectomy does not reduce postoperative compensatory sweating. J Vasc Surg. 2003; 37(1):124-8. DOI: 10.1067/mva.2002.23. View

Heckmann M, Schaller M, Ceballos-Baumann A, Plewig G . Botulinum beyond wrinkles. Dermatol Surg. 1998; 23(12):1221-2. DOI: 10.1111/j.1524-4725.1997.tb00480.x. View

Heidemann E, Licht P . A comparative study of thoracoscopic sympathicotomy versus local surgical treatment for axillary hyperhidrosis. Ann Thorac Surg. 2012; 95(1):264-8. DOI: 10.1016/j.athoracsur.2012.08.103. View

Groscurth P . Anatomy of sweat glands. Curr Probl Dermatol. 2002; 30:1-9. DOI: 10.1159/000060678. View

Kao M . Laser endoscopic sympathectomy for palmar hyperhidrosis. Lasers Surg Med. 1992; 12(3):308-12. DOI: 10.1002/lsm.1900120311. View

White W, Makin I, Barthe P, Slayton M, Gliklich R . Selective creation of thermal injury zones in the superficial musculoaponeurotic system using intense ultrasound therapy: a new target for noninvasive facial rejuvenation. Arch Facial Plast Surg. 2007; 9(1):22-9. DOI: 10.1001/archfaci.9.1.22. View

Haider A, Solish N . Focal hyperhidrosis: diagnosis and management. CMAJ. 2005; 172(1):69-75. PMC: 543948. DOI: 10.1503/cmaj.1040708. View

Ojimba T, Cameron A . Drawbacks of endoscopic thoracic sympathectomy. Br J Surg. 2004; 91(3):264-9. DOI: 10.1002/bjs.4511. View

Ibrahim M, Menna C, Andreetti C, Ciccone A, DAndrilli A, Maurizi G . Two-stage unilateral versus one-stage bilateral single-port sympathectomy for palmar and axillary hyperhidrosis. Interact Cardiovasc Thorac Surg. 2013; 16(6):834-8. PMC: 3653463. DOI: 10.1093/icvts/ivt039. View

10.

Ichikawa K, Miyasaka M, Aikawa Y . Subcutaneous laser treatment of axillary osmidrosis: a new technique. Plast Reconstr Surg. 2006; 118(1):170-4. DOI: 10.1097/01.prs.0000221005.86108.0d. View

11.

Zhu L, Du Q, Chen L, Yang S, Tu Y, Chen S . One-year follow-up period after transumbilical thoracic sympathectomy for hyperhidrosis: outcomes and consequences. J Thorac Cardiovasc Surg. 2013; 147(1):25-8. DOI: 10.1016/j.jtcvs.2013.08.062. View

12.

Lecouflet M, Leux C, Fenot M, Celerier P, Maillard H . Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients. J Am Acad Dermatol. 2013; 69(6):960-4. DOI: 10.1016/j.jaad.2013.08.002. View

13.

Birklein F, Eisenbarth G, Erbguth F, Winterholler M . Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up. J Invest Dermatol. 2003; 121(6):1312-6. DOI: 10.1046/j.1523-1747.2003.12620.x. View

14.

Bergkvist L, ENGEVIK L . The surgical treatment of axillary hyperhidrosis. Br J Surg. 1979; 66(7):482-4. DOI: 10.1002/bjs.1800660709. View

15.

Frevert J . Xeomin: an innovative new botulinum toxin type A. Eur J Neurol. 2009; 16 Suppl 2:11-3. DOI: 10.1111/j.1468-1331.2009.02879.x. View

16.

Yang J, Tan J, Ye G, Gu W, Wang J, Liu Y . T3/T4 thoracic sympathictomy and compensatory sweating in treatment of palmar hyperhidrosis. Chin Med J (Engl). 2007; 120(18):1574-7. View

17.

Adefusika J, Brewer J . OnabotulinumtoxinA therapy for compensatory hyperhidrosis. J Cosmet Dermatol. 2013; 12(3):232-4. DOI: 10.1111/jocd.12049. View

18.

Kreyden O, Scheidegger E . Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin Dermatol. 2004; 22(1):40-4. DOI: 10.1016/j.clindermatol.2003.12.029. View

19.

Manca D, Valls-Sole J, Callejas M . Excitability recovery curve of the sympathetic skin response in healthy volunteers and patients with palmar hyperhidrosis. Clin Neurophysiol. 2000; 111(10):1767-70. DOI: 10.1016/s1388-2457(00)00394-1. View

20.

Ibrahim O, Kakar R, Bolotin D, Nodzenski M, Disphanurat W, Pace N . The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial. J Am Acad Dermatol. 2013; 69(1):88-95. DOI: 10.1016/j.jaad.2013.02.013. View